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INTRODUCTION
Hepatic amyloidosis is a rare disease that presents as an 
infiltrative disease involving liver. Amyloidosis is a systemic 
disease characterized by the extracellular deposition of 
amyloid protein in many organs.
1-4 Progressive organ in-
volvement leads to organ malfunction and death usually 
resulting from renal and/or cardiac involvement. Liver and 
spleen are major sites of involvement.
1-3 The wide range of 
presenting symptoms encountered makes rapid clinical 
diagnosis difficult. None of the present imaging techniques 
is capable of specifically demonstrating the presence of 
amyloid. Even when suspected clinically and radiologically, 
the diagnosis of amyloidosis depends on a tissue biopsy to 
confirm the presence of amyloid deposits.
5
To provide more detailed understanding of hepatic amy-
loidosis, here a case of amyloidosis involving liver is presented 
with radiological imaging findings including computed 
tomography (CT). 
CASE 
A 45-year-old female was admitted with the complaint of 
generalized edema. She got about 6 kg of weight gain during 
recent one week. She had dizziness, dyspnea, anorexia, 
nausea and epigastric discomfort. She presented physical 
examination findings including neck vein engorgement, 
abdominal distension, hepatomegaly and pitting edema. She 
had history of syncope about one month ago, but brain 
magnetic resonance imaging (MRI) showed no abnormal 
finding. The laboratory findings showed leukocyte count of 
11,500/mm
3, hemoglobin level of 9.1 g/dL and platelet count 
of 284,000/mm
3. Biochemical tests showed that the serum 
level of alanine aminotransferase was 30 IU/L, aspartate 
aminotransferase was 55 IU/L, and alkaline phosphatase 
elevated up to 398 IU/L. Serum albumin was 3.7 g/dL, total 
bilirubin was 1.2 mg/dL, and creatinine was 2.3 mg/dL. 
Alpha fetoprotein was less than 1 ng/mL. The results for 
hepatitis B surface antigen and anti-HBs were negative. Urine 
analysis showed albumin positive, and otherwise negative.
Renal disease was suspected and abdominal ultrasonography 
was done. Liver showed diffuse coarse echo and hypoechoic 
pattern with hepatomegaly (Fig. 1A). Both kidneys showed 
also diffuse increased cortical echo suggesting renal 
parenchymal disease (Fig. 1B).
Dynamic contrast enhanced CT was taken because of 
abnormal liver echo and size. On arterial phase, there was no 
enhancing lesion in liver (Fig. 2). On portal phase, size of 
liver increased, and especially left lobe showed bulging 
contoured enlargement and ill-defined hypoattenuation (Fig. 
3A, 3B). There were multiple ill-defined hypoattenuatted 
areas in right lobe. Spleen showed normal enhancement, but 
size increased. Both kidneys also showed multiple irregular 
decreased attenuation lesions (Fig. 3C). Because liver showed 
decreased echo on ultrasonography, it was assumed that it 
was not fatty infiltration. These CT findings suggested diffuse Yong Moon Shin. Hepatic amyloidosis  81
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Figure 1. (A) Ultrasonography of a 45-year-old woman showed hepatomegaly with diffuse decreased and coarse echo of liver. (B) 
Ultrasonography of right kidney revealed diffuse increased echo in renal cortex comparing with adjacent liver parenchymal echo.
Figure 2. Arterial phase of CT showed no mass in liver.
infiltrative disease, so liver biopsy was done. Percutaneous 
fine-needle-aspiration biopsy was performed under ultrasound 
guidance, and a histological examination of the biopsy 
specimen showed amorphous material stained by Congo red 
stain. The deposit demonstrated characteristic positive 
birefringence with polarized light. Biopsy results led to a 
final diagnosis of extensive amyloidosis. 
Additional examinations were done to evaluate the extent 
of amyloidosis involvement. 2D Doppler echocardiography 
showed enlarged both atrium and thickened left ventricle 
wall with normal vetnrcular contractility, which suggested 
infiltrative disease such as amyloidosis. Bone marrow 
aspiration and colonic mucosa biopsy showed also amyloidosis. 
Urine Immunoelectrophoresis showed abnormal zone of 
restriction in kappa light chain, suggesting Bence-Jones 
protein, free kappa type.
She was diagnosed as systemic amyloidosis, and chemo-
therapy was done. However, hepatic failure with hepatic 
encephalopathy was aggravated and she got discharged in a 
moribund state.  
DISCUSSION
Amyloid is defined as a substance which: (1) stains positively 
with Congo red, (2) exhibits apple green birefringence by 
polarization microscopy, (3) shows aggregations of approxi-
mately 10 nm wide fibrils on electron microscopy, (4) exhibits 
a β-pleated sheet configuration, and (5) shows resistance to 
proteases other than pronase.
5 Progressive deposition of 
amyloid compresses and replaces normal tissue, and this 
leads to organ dysfunction and a wide variety of clinical 
syndromes, some of which have severe pathophysiological 
consequences.
Amyloidosis is usually seen in a systemic form, but 
10-20% of cases can be localized.
4 Men are affected more 
than women, and the mean age of presentation is 55-60 years. 
Some causes of secondary amyloidosis are multiple myeloma 
(10-15%), rheumatoid arthritis (20-25%), tuberculosis (50%), 
or familial Mediterranean fever (26-40%).
4 Approximately 
one-third of patients with primary amyloidosis develop 
congestive heart failure. It is the leading cause of death in 
patients with primary and myeloma-related amyloidosis. 
In case of hepatic amyloidosis, amyloid is deposited in the 
parenchyma, along the sinusoids within the space of Disse, 
or in blood vessel walls. Hepatocytes are severely compressed 
by extensive accumulation of amyloid and they may atrophy 
or nearly disappear. In advanced cases with massive infiltration, 
the liver is enlarged with rubbery elastic consistency, and it 82  The Korean Journal of Hepatology Vol. 17. No. 1, March 2011
Figure 3. (A) Portal phase of CT showed ill-defined hypoattenuated
area in liver left lobe. (B) Another level of liver showed similar 
hypoattenuated lesion in liver, in both lobes. (C) Ill-defined 
infiltrative lesions were also noted in right lobe. Both kidneys 
showed multiple ill-defined low attenuated lesions, too.
may show ‘lardaceous liver’ appearance on cut surface.
1
Although hepatic involvement is very common in patients 
with amyloidosis, the clinical manifestations of hepatic 
involvement are usually mild. Symptomatic involvement, 
including rupture, portal hypertension or hepatic failure, is 
rare. Hepatomegaly and a borderline abnormal liver function 
test are the most frequent findings in patients with hepatic 
amyloidosis.
3,5 However, serious symptoms such as hepatic 
failure and portal hypertension may develop. Spontaneous 
rupture and massive hemorrhage may occur; therefore, 
needle biopsy should be performed carefully. In one report 
77% of the patient had an associated nephrotic syndrome, 
congestive heart failure, peripheral neuropathy, or orthostatic 
hypotension. Other signs of hepatic amyloidosis included 
proteinuria (88%), elevated serum alkaline phospatase (86%), 
abnormal serum protein electrophoresis (monoclonal protein 
or hypogammaglobulinemia, 64%), hyposplenism on the 
peripheral blood smear (62%), defined by the presence of 
Howell-Jolly bodies; and hepatomegaly (81%) disproportional 
to the liver enzyme abnormalities. Liver function tests were 
not sensitive or specific. Normal levels of aspartate amino-
transferase, and bilirubin were seen in 32%. The median 
survival of the entire group was nine months.
2,3
Radiological findings of hepatic involvement are non- 
specific, Amorphous or irregular calcifications were occasionally 
identified within the amyloid deposit. Definitive diagnosis 
requires biopsy confirmation, as CT findings are nonspecific.
5,6 
The ultrasonographic findings of primary hepatic amyloidosis 
have not been well described. In one reported case, hetero-
geneous echogenicity was seen in the liver as in the present 
case. 
The frequent findings of conventional precontrast and 
contrast-enhanced CT are an enlarged liver with heterogeneous 
decreased attenuation.
1,6 Calcification may be seen rarely in 
the hepatic parenchyma. The hepatic parenchyma infiltrated 
more highly by amyloid may appear as focal hypoattenuating 
areas on contrast- enhanced CT scans. This finding probably 
resulted from impairment of blood flow due to vascular 
involvement and diffuse parenchymal infiltration of amyloid.
1 
Delayed phase CT scans showed delayed enhancement with 
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the presence of some focal hypoattenuating areas in the liver. 
The delayed enhancement was probably due to delayed 
passage of contrast medium in the involved parenchyma, 
and the hepatic parenchyma with prominent infiltration 
might appear as the focal hypoattenuating areas. Kim et al
5 
suggested that hepatic amyloidosis have characteristic 
features of hepatic contour; and asymmetric and triangular 
hepatomegaly with the apex at the falciform ligament. This 
finding was believed to be the result of mild atrophic change 
of the lateral border of both hepatic lobes, in spite of hepatic 
enlargement reported in other infiltrative diseases.
MR imaging has been used for the evaluation of primary 
hepatic amyloidosis. One report showed that, although T2 
value of the hepatic parenchyma was not changed, T1 value 
was increased and it could beused to monitoring of chemo-
therapy.
1 However, the reason for high signal intensity on T1 
is not known. 
One report showed that the deposition of amyloid in the 
spleen was identified in about 83% of patients at the time of 
autopsy.
1 Amyloid tends to infiltrate in the red pulp or blood 
vessel walls. The spleen may swell and harden by massive 
infiltration, and ‘bacon spleen’ appearance may be seen on 
cut surface in advanced cases. Splenic involvement is usually 
asymptomatic. Hyposplenism may occur and potentially 
increase the risk of serious infection. Spontaneous splenic 
rupture is a known consequence of splenic amyloidosis. CT 
findings of primary splenic amyloidosis include splenomegaly, 
calcification and poor contrast enhancement of the splenic 
parenchyma on conventional contrast-enhanced CT scans. 
Mild delayed enhancement was noted in the spleen on 
delayed phase CT scans.
1,4 In the spleen, arterial phase CT 
showed the lack of parenchymal enhancement, and T2-weighted 
MR imaging showed decreased signal intensity.
2
SUMMARY
Amyloidosis can demonstrate a wide spectrum of disease 
in nearly every organ and tissue type. Hepatic involvement 
shows 1) hepatomegaly, 2) inhomogeneous areas of decreased 
attenuation on CT, with focal or diffuse involvement, 3) 
delayed enhancement with intravenously administered contrast 
material, or rarely 4) hepatic rupture or marked hepatic 
calcification. 
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